Pitcairn Co. Sells 4,051 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

by · The Cerbat Gem

Pitcairn Co. decreased its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG – Free Report) by 17.7% in the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 18,778 shares of the medical equipment provider’s stock after selling 4,051 shares during the period. Intuitive Surgical comprises 0.5% of Pitcairn Co.’s portfolio, making the stock its 28th biggest position. Pitcairn Co.’s holdings in Intuitive Surgical were worth $9,225,000 at the end of the most recent reporting period.

Other hedge funds also recently modified their holdings of the company. Mirador Capital Partners LP increased its holdings in shares of Intuitive Surgical by 1.4% during the third quarter. Mirador Capital Partners LP now owns 3,526 shares of the medical equipment provider’s stock worth $1,732,000 after buying an additional 50 shares in the last quarter. Advisors Asset Management Inc. increased its holdings in shares of Intuitive Surgical by 18.1% during the first quarter. Advisors Asset Management Inc. now owns 7,380 shares of the medical equipment provider’s stock worth $2,945,000 after buying an additional 1,129 shares in the last quarter. Consolidated Planning Corp increased its holdings in shares of Intuitive Surgical by 17.4% during the third quarter. Consolidated Planning Corp now owns 8,099 shares of the medical equipment provider’s stock worth $3,979,000 after buying an additional 1,198 shares in the last quarter. Healthcare of Ontario Pension Plan Trust Fund increased its holdings in shares of Intuitive Surgical by 617.1% in the second quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 89,069 shares of the medical equipment provider’s stock valued at $39,622,000 after purchasing an additional 76,649 shares in the last quarter. Finally, Swiss National Bank increased its holdings in shares of Intuitive Surgical by 0.3% in the third quarter. Swiss National Bank now owns 1,052,800 shares of the medical equipment provider’s stock valued at $517,209,000 after purchasing an additional 3,400 shares in the last quarter. Institutional investors and hedge funds own 83.64% of the company’s stock.

Intuitive Surgical Stock Down 0.5 %

Shares of NASDAQ ISRG opened at $547.87 on Friday. The company’s fifty day moving average is $504.73 and its 200-day moving average is $463.02. The stock has a market cap of $195.14 billion, a price-to-earnings ratio of 88.08, a P/E/G ratio of 5.41 and a beta of 1.39. Intuitive Surgical, Inc. has a twelve month low of $304.50 and a twelve month high of $552.00.

Intuitive Surgical (NASDAQ:ISRG – Get Free Report) last announced its quarterly earnings results on Thursday, October 17th. The medical equipment provider reported $1.56 earnings per share for the quarter, topping analysts’ consensus estimates of $1.24 by $0.32. The company had revenue of $2.04 billion for the quarter, compared to analysts’ expectations of $2.01 billion. Intuitive Surgical had a net margin of 28.51% and a return on equity of 13.41%. On average, research analysts anticipate that Intuitive Surgical, Inc. will post 5.45 EPS for the current fiscal year.

Insider Activity at Intuitive Surgical

In related news, insider Jamie Samath sold 22,903 shares of the business’s stock in a transaction on Friday, November 8th. The shares were sold at an average price of $525.00, for a total value of $12,024,075.00. Following the sale, the insider now directly owns 8,757 shares of the company’s stock, valued at approximately $4,597,425. The trade was a 72.34 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, General Counsel Gary Loeb sold 300 shares of the business’s stock in a transaction on Monday, September 9th. The shares were sold at an average price of $475.00, for a total transaction of $142,500.00. Following the completion of the sale, the general counsel now directly owns 1,595 shares in the company, valued at $757,625. This represents a 15.83 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 50,935 shares of company stock valued at $26,305,169. 0.90% of the stock is owned by corporate insiders.

Analyst Ratings Changes

A number of analysts recently weighed in on ISRG shares. Raymond James raised their price target on shares of Intuitive Surgical from $500.00 to $540.00 and gave the company an “outperform” rating in a report on Monday, October 14th. JPMorgan Chase & Co. raised their price target on shares of Intuitive Surgical from $495.00 to $575.00 and gave the company an “overweight” rating in a report on Friday, October 11th. BTIG Research set a $535.00 price target on shares of Intuitive Surgical in a report on Friday, October 18th. Oppenheimer reissued a “market perform” rating on shares of Intuitive Surgical in a report on Friday, October 18th. Finally, Stifel Nicolaus raised their price target on shares of Intuitive Surgical from $475.00 to $525.00 and gave the company a “buy” rating in a report on Friday, October 18th. One equities research analyst has rated the stock with a sell rating, five have assigned a hold rating and fourteen have given a buy rating to the company’s stock. According to MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $524.61.

Check Out Our Latest Research Report on ISRG

Intuitive Surgical Company Profile

(Free Report)

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.

Featured Stories